The aim of the study is to examine the feasibility of using GlucoCEST to evaluate subtle BBB dysfunction in the mouse brain, by comparing it with conventional gadolinium DCE. DCE and GlucoCEST showed no significant differences between WT and 5XFAD mice (3 months). However, the degree of the response after injection was similar for DCE and GlucoCEST for all animals except one, indicating shared contributions to the signal and supporting the potential for biodegradable d-glucose as a cheap, low-risk alternative/complement to DCE MRI. More work is required to assess GlucoCEST sensitivity to low-level BBB dysfunction, such as in Alzheimer’s disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords